Global At-Home Drug of Abuse (DOA) Testing Market is segmented By Product Type (Rapid DOA Test Kits, Breath Analyzers, Other) By Sample (Urine, Saliva, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
Global At-Home Drug of Abuse (DOA) Testing Market is expected to reach at a high CAGR during the forecast period 2024-2031.
Drug abuse testing is a procedure that tests for illicit or improperly utilized prescription medication in a person's system. Drug tests may take a variety of forms, each with unique benefits and drawbacks.
Drugs of Abuse (DOA) tests are used to screen for the presence of abused drugs in a specimen obtained from a subject in a clinic, home, workplace, sports, or insurance setting. Tests in blood, urine, sweat, saliva, hair or other specimen matrices are possible.
Market Summary
| Metrics | Details |
| CAGR | High |
| Market Size Available for Years | 2022-2031 |
| Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | By Product Type, By Sample, and By Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report – Request for Sample
Market Dynamics
The increasing overdose of drugs and diagnosis of these drugs
The leading cause of drug overdose deaths is opioids, particularly synthetic opioids (other than methadone). A public health crisis is triggered by an unexpected rise in drug overdose deaths. Even with prescription medications, people are becoming more conscious of the risks associated with substance abuse and the possibility of addiction.
Due to increased knowledge, there is a larger need for instruments to track drug usage, both for oneself and possibly for loved ones who are addicted. For instance, according to the report by the National Institute of Drug Abuse in 2022, nearly 108,000 persons in the U.S. died from drug-involved overdose in 2022, including from illicit or prescription drugs.
These tests, however, may be used to monitor treatment and recovery. Hence, the increasing number of drug overdose cases and their diagnosis is expected to drive the market.
Limitations of these testing devices
A drug test result for a urine specimen that contains an unidentified adulterant or an interfering substance, has abnormal physical characteristics, or contains an endogenous substance at an abnormal concentration, preventing at-home drug tests from completing or obtaining a valid drug test result. This test's at-home component is fairly sensitive to the presence of drugs in the urine.
Market Segment Analysis
The global at-home drug of abuse testing market is segmented based on product type, sample and region.
Rapid DOA Test Kits segment is expected to dominate the market growth
Rapid Screen tests use one-of-a-kind monoclonal antibodies to detect specific drugs of abuse (DOA) and their metabolites in urine samples with high sensitivity and specificity. DOA rapid tests are qualitative, lateral flow devices based on the drug-competitive inhibition immunoassay.
The cut-off concentration for specific drug of abuse and its metabolites has been developed for all of our DOA screening test devices at the concentration standards set by NIDA (the National Institute on Drug Abuse of the United States) for the qualitative detection of corresponding drugs in human urine specimens.
For example, Atlas medical a UK based company’s, Atlas Medical Drug of Abuse (DOA) Rapid Tests can detect a wide variety of drugs in urine and saliva samples. The tests are based on lateral flow immunoassay rapid tests and are available in strip, cassette, multi-dip, multi-cassette, and multi-drug cup formats for professional, forensic, and work-screening applications. Atlas Medical can provide custom drug combinations to customers in addition to the standard selection of multi-drug tests. Their DOA breath analyzers are simple to use and provide clear, accurate, and consistent results.
Market Geographical Share
North America is expected to hold a significant position in the at-home drug of abuse testing market share
North America region accounted for the largest market share in the global at-home drug of abuse testing market. The accessibility and consumption of illegal drugs is a serious problem in North America. This increases the need for easy-to-use drug monitoring tools, whether for private or court-ordered purposes.
For instance, according to a report in 2022 by the Addiction Center, it stated that addiction is a serious problem that affects millions of people and more than 70% of people who tried an illegal drug before the age of 13 have an addiction to alcohol or drugs. Almost 21 million Americans have at least one addiction, yet only 10% of them receive treatment. About 25% of people who use illicit drugs develop an addiction.
Additionally, according to the results released by the US Department of Health and Human Services in 2023, it reported that among people aged 12 or older in 2021, 61.2 million people (or 21.9 percent of the population) used illicit drugs in 2022. The most commonly used illicit drug was marijuana, which 52.5 million people used. Thus, the above factors are expected to hold the region in the dominant position during the forecast period.
COVID-19 Impact Analysis
Due to the strict lockdown measures and social distancing implemented to combat the spread of the coronavirus, an increase in alcohol and drug abuse has resulted, which has led to isolated overdosing and posing a significant challenge for drug addicts. Hence, with the lockdown restrictions, people preferred at-home drug abuse testing.
Market Companies
The major global players in the market include UCP Biosciences Inc., Atlas Medical, Assure Tech (Hangzhou) Co. Ltd., Biopanda Reagents, Home Health (U.K.) Ltd., Phamatech, Inc., Psychemedics Corporation, Cliawaived, Inc., Co-Innovation Biotech Co., Ltd. and MyDiagnostics among others.
Why Purchase the Report?
- To visualize the global at-home drug of abuse testing market segmentation based on product type, sample and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of at-home drug of abuse testing market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global at-home drug of abuse testing market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
